Jyotsna Ghai - Feb 9, 2025 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Operating Officer
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Feb 9, 2025
Transactions value $
$0
Form type
4
Date filed
2/11/2025, 05:57 PM
Previous filing
Jan 6, 2025
Next filing
Feb 25, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +250 +8.24% 3.28K Feb 9, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -250 -7.69% 3K Feb 9, 2025 Common Stock 250 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The RSUs vest in 16 equal quarterly installments over four years measured from February 9, 2024.